Alcohol Abuse Is on the Rise, but Doctors Too Often Fail to Treat It
Carrie Mintz, MD, assistant professor of psychiatry
New Alzheimer’s drug clouds outlook for Medicare premiums next year
Rachel Sachs, associate professor of law
Human activity imperils one of the Earth’s great survivalists: dragonflies
We still have time to implement policies that pull us back from the brink, but the window is closing. Without action, we will be remembered for debasing the environment so badly that it finally altered or eradicated even the toughest creatures in Earth’s history, writes Michael Moore, post-doctoral fellow with the Living Earth Collaborative.
Poverty in 2021 looks different than in 1964 – but the US hasn’t changed how it measures who’s poor since LBJ began his war
If the U.S. ever hopes to finally win the war LBJ began in 1964, the poor need to be seen in order for the government to lift them out of poverty, writes Mark Rank, Herbert S. Hadley Professor of Social Welfare.
Concerns about unreported child abuse loom large despite easing Covid restrictions
Melissa Jonson-Reid, the Ralph and Muriel Pumphrey Professor in Social Work
Swing vote to soft power: How Chief Justice John Roberts is exerting influence
Lee Epstein, the Ethan A.H. Shepley Distinguished University Professor
How everyone on Medicare could end up paying for the pricey new Alzheimer’s drug
Rachel Sachs, associate professor of law
FDA head urges probe of agency’s dealings with Biogen, maker of controversial new Alzheimer’s drug
Rachel Sachs, associate professor of law
Judge David Tatel’s lack of eyesight never defined him, but his blindness is woven into the culture of the influential appeals court in D.C.
Travis Crum, associate professor of law
View More Stories